IND submission is a major milestone in the life of your drug. We can provide all supporting analytical data to help ensure a smooth application process.
We have the expertise, flexibility, and resources to provide a full range of pharmaceutical API custom development services at every stage of the lifecycle.
We can provide lab-, kilo- and pilot-scale manufacturing for preclinical studies and all phases of clinical trials, supplying milligram to kilogram quantities.
Cambrex brings more than 40 years of generic API manufacturing experience to its pharmaceutical partners. From our sites in Italy, Sweden, and the USA, we are a leading global supplier of generic APIs.
Cambrex offers cutting-edge capabilities in peptide development and manufacturing, combining innovative technologies, diverse applications and specialized expertise to meet the growing demand for peptide-based therapeutics.
Drug substance tech transfer sounds so simple on the surface, but it’s a complex activity carrying a number of technical, regulatory, and quality risks. Cambrex specializes in seamless technology transfers and quick onboarding to keep your program on track.
At Cambrex, we provide a range of technologies equipped to solve your API manufacturing challenges, and we are flexible enough to handle the most complex molecules.
At Snapdragon Chemistry, now part of Cambrex, our chemists specialize in creating custom solutions and technologies to take on your toughest process development and production challenges. This includes expertise in designing and building reactors that enable seamless technology transfer as a process scales up for commercial manufacturing.
You can rely on our extensive portfolio of analytical development solutions and testing services to rapidly advance your molecule for the greatest chance of success.
Cambrex’s experienced analysts are well-equipped to ensure microbial testing is of the highest quality for our customers and delivered with a quick and reliable turnaround.
We’re solid state chemistry experts who can deliver timely, phase-appropriate solutions to optimize the physical stability of your API, develop a more bioavailable formulation or overcome other challenges.
Cambrex and Q1 Scientific’s stability storage and sample management capabilities provide a variety of pharmaceutical storage conditions, with walk-in and reach-in chambers that meet all ICH Q1A requirements.
Cambrex offers extensive development services tailored to meet your drug product needs in early development. From pre-formulation to Phase II, we ensure your products are developed with speed, flexibility, and quality in mind.
Whether you need rapid development, flexible manufacturing solutions, or high-quality production, Cambrex is your trusted partner for advancing your drug product from concept to the clinic.
Cambrex is here to support you in early-phase development. Our development experts apply their ingenuity and skill to address your unique challenges.
Our teams of creative problem-solvers work closely with you to accelerate drug development timelines, optimize processes, and meet regulatory requirements.
We understand that the commercial phase of drug development can be challenging, especially when it comes to manufacturing at scale and meeting changing market demands.
Cambrex is a leading global supplier of more than 70 generic APIs, as well as intermediates and derivatives.
Search results for ''
The life sciences industry has expanded tremendously in recent decades, causing leaders to leverage new solutions to respond to growing geopolitical and regulatory demands. Contract development and manufacturing organizations (CDMOs),…
At Cambrex, we have a global network of drug development capabilities operationalized across 13 sites throughout North America and Europe. While many CDMOs operate with silos, Cambrex’s leadership and scientific…
Snapdragon Chemistry, a Cambrex Company, won the 2023 CPHI Pharma Award for API Development for their innovative process development of a continuous flow-manufacturing system, which helps to recycle unwanted elements…
Over the past two decades, the pharmaceutical industry has experienced a notable shift in sustainability practices, with most organizations now integrating Environmental, Social, and Governance (ESG) programs into their core…
When we begin scoping projects with new clients, we frequently hear the question, “What will my experience be like once we start working together?” While it’s hard to explain an…
Our recent article in Organic Process Research & Development delves into the technology transfer and process development of danicopan, an orally administered complement Factor D (FD) inhibitor. Danicopan is used…
At Cambrex, we understand the critical importance of ensuring the safety and integrity of your pharmaceutical products. Nitrosamines, a class of potent carcinogenic impurities, pose significant risks if present in…
Continuous manufacturing is now a well-established technology for pharmaceutical manufacturing. As drug substance molecular complexity continues to increase, flow chemistry is becoming an essential enabling technology. Chemical methods once restricted…
Continuous chemical manufacturing technology has been in use for more than 100 years producing high-volume commodity chemicals. However, it was not until the early 2000s that the technology caught the…
In our article published in Angewandte Chemie International Edition, we discuss how we developed of a flow chemistry process for asymmetric propargylation using allene gas as a reagent. The connected…